CardioAcademic (@cardioacademic) 's Twitter Profile
CardioAcademic

@cardioacademic

Comunidad especializada en Cardiología, con el objetivo de fomentar la educación continúa a través del trabajo y participación en conjunto.

ID: 3026810162

linkhttp://www.cardioacademic.org.mx calendar_today18-02-2015 18:06:03

20,20K Tweet

3,3K Followers

619 Following

CardioAcademic (@cardioacademic) 's Twitter Profile Photo

🔔 Información Importante: Métodos de Pago para CardioAcademic 🔔 Para facilitar su inscripción, hemos habilitado los siguientes métodos de pago: 1️⃣ Transferencia bancaria: Datos bancarios disponibles en la siguiente semana.

🔔 Información Importante: Métodos de Pago para CardioAcademic 🔔

Para facilitar su inscripción, hemos habilitado los siguientes métodos de pago:

1️⃣ Transferencia bancaria: Datos bancarios disponibles  en la siguiente semana.
Ahmed Bennis (@drbennisahmed) 's Twitter Profile Photo

Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension Sacubitril/allisartan is effective for the treatment of hypertension and well tolerated in Chinese patients jacc.org/doi/10.1016/j.…

Efficacy and Safety of Sacubitril/Allisartan for the Treatment of Primary Hypertension

Sacubitril/allisartan is effective for the treatment of hypertension and well tolerated in Chinese patients

jacc.org/doi/10.1016/j.…
Scott Isaacs (@scottisaacsmd) 's Twitter Profile Photo

This study shows diet intervention's powerful impact on type 2 diabetes remission. Low-calorie approach empowers patients to reverse their condition. Highlights need for long-term support to maintain results. #DiabetesReversal #NutritionMedicine thelancet.com/journals/landi…

This study shows diet intervention's powerful impact on type 2 diabetes remission. Low-calorie approach empowers patients to reverse their condition. Highlights need for long-term support to maintain results. #DiabetesReversal #NutritionMedicine
thelancet.com/journals/landi…
NEJM (@nejm) 's Twitter Profile Photo

Clinical Implications of Basic Research: Discovery of GLP-1–Based Drugs for the Treatment of Obesity nej.md/3XOepUg #Endocrinology

Clinical Implications of Basic Research: Discovery of GLP-1–Based Drugs for the Treatment of Obesity nej.md/3XOepUg 

#Endocrinology
American College of Cardiology (@accintouch) 's Twitter Profile Photo

The AVATAR trial showed that early aortic valve replacement was beneficial at preventing adverse events among patients with asymptomatic severe #vhdAS. bit.ly/331A29L

European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

Anticoagulation to prevent arterial #thromboembolism in #cancer patients: does primary tumor site make a difference? A new meta-analysis published in #EHJPharmacotherapy 👉 bit.ly/3ZtRRJv EHJ-CVP Editor-in-Chief Felice Gragnano Mattia Galli

Anticoagulation to prevent arterial #thromboembolism in #cancer patients: does primary tumor site make a difference? A new meta-analysis published in #EHJPharmacotherapy 👉 bit.ly/3ZtRRJv 

<a href="/EditorEHJCVP/">EHJ-CVP Editor-in-Chief</a> <a href="/FeliceGragnano/">Felice Gragnano</a> <a href="/MattiaGalli10/">Mattia Galli</a>
JAMA Cardiology (@jamacardio) 's Twitter Profile Photo

In high-risk patients who had undergone PCI presenting with or without ACS, there was no incremental benefit from routine surveillance stress-testing as compared with standard-care alone during follow-up. ja.ma/4e2GsVG Duk-Woo Park

In high-risk patients who had undergone PCI presenting with or without ACS, there was no incremental benefit from routine surveillance stress-testing as compared with standard-care alone during follow-up. ja.ma/4e2GsVG <a href="/dukwoo_park/">Duk-Woo Park</a>
World Heart Federation (@worldheartfed) 's Twitter Profile Photo

Stop scrolling and #UseHeart! It only takes one minute. Go sign the first-ever global petition to fight cardiovascular disease: worldheartday.org/petition #WorldHeartDay #HeartYes #UseYourVote

PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

Antegrade CTO PCI - what you need to know Learn about the basics of mastering antegrade wire 🪡 escalation (AWE), which guidewires and microcatheters to choose and how to use them, what to do when AWE fails, and much more! pcronline.com/Cases-resource… #EuroPCR

Antegrade CTO PCI - what you need to know

Learn about the basics of mastering antegrade wire 🪡 escalation (AWE), which guidewires and microcatheters to choose and how to use them, what to do when AWE fails, and much more!

pcronline.com/Cases-resource…

#EuroPCR
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Among patients undergoing #AFib ablation from 2014 to 2023, preprocedural use of GLP-1 receptor agonists was not assoc. w/ reduced risk of AF recurrence or assoc. adverse outcomes following ablation. bit.ly/3TDCRVH #JACCCEP #EPeeps #epAblation

Among patients undergoing #AFib ablation from 2014 to 2023, preprocedural use of GLP-1 receptor agonists was not assoc. w/ reduced risk of AF recurrence or assoc. adverse outcomes following ablation. bit.ly/3TDCRVH

#JACCCEP #EPeeps #epAblation
American College of Cardiology (@accintouch) 's Twitter Profile Photo

Are you looking for more information on Coronary Artery Revascularization? Explore the ACC #Revasc guideline hub with a guideline pocket guide, patient resources, slides and more. bit.ly/3yf2KPY #ACCLATAM

Are you looking for more information on Coronary Artery Revascularization? 

Explore the ACC #Revasc guideline hub with a guideline pocket guide, patient resources, slides and more. bit.ly/3yf2KPY #ACCLATAM
American College of Cardiology (@accintouch) 's Twitter Profile Photo

The PROACT trial found adding enalapril to standard care during chemotherapy did not prevent cardiotoxicity in patients receiving high-dose anthracycline-based chemotherapy. Read more on the trial: bit.ly/3ZnZWiV #ACCLATAM

The PROACT trial found adding enalapril to standard care during chemotherapy did not prevent cardiotoxicity in patients receiving high-dose anthracycline-based chemotherapy.

Read more on the trial: bit.ly/3ZnZWiV #ACCLATAM
American College of Cardiology (@accintouch) 's Twitter Profile Photo

The PREVENT trial showed preventive PCI of focal non-FFR-positive plaques that are angiographically >50% and have evidence of vulnerability on intravascular imaging along with OMT is superior to OMT for clinical outcomes at 2 years. bit.ly/3ZjwquI #ACCLATAM

The PREVENT trial showed preventive PCI of focal non-FFR-positive plaques that are angiographically &gt;50% and have evidence of vulnerability on intravascular imaging along with OMT is superior to OMT for clinical outcomes at 2 years. bit.ly/3ZjwquI #ACCLATAM
American College of Cardiology (@accintouch) 's Twitter Profile Photo

The ULTIMATE-DAPT trial showed that compared w/ standard 12-month DAPT with aspirin and ticagrelor, 1-month DAPT followed by de-escalation to ticagrelor monotherapy reduces bleeding without an increase in ischemic events at 1 year among patients undergoing PCI for ACS. Get the

The ULTIMATE-DAPT trial showed that compared w/ standard 12-month DAPT with aspirin and ticagrelor, 1-month DAPT followed by de-escalation to ticagrelor monotherapy reduces bleeding without an increase in ischemic events at 1 year among patients undergoing PCI for ACS. Get the
American College of Cardiology (@accintouch) 's Twitter Profile Photo

Earlier this year, the ACC, AHA and other societies released a PAD Guideline. This Guideline-at-a-Glance highlights practice-changing recommendations from the guideline to accelerate adoption into clinical practice: bit.ly/3JZvxi7 #PADAwarenessMonth

Earlier this year, the ACC, AHA and other societies released a PAD Guideline.

This Guideline-at-a-Glance highlights practice-changing recommendations from the guideline to accelerate adoption into clinical practice: bit.ly/3JZvxi7 #PADAwarenessMonth
CardioAcademic (@cardioacademic) 's Twitter Profile Photo

🌟 ¡No te pierdas CardioAcademic 2024! 📷Este año contaremos con ponentes de primer nivel académico en el campo de la cardiología, compartiendo los últimos avances y estudios clínicos. 📷📷¡Únete y aprende de los mejores expertos internacionales!

🌟 ¡No te pierdas CardioAcademic 2024! 📷Este año contaremos con ponentes de primer nivel académico en el campo de la cardiología, compartiendo los últimos avances y estudios clínicos. 📷📷¡Únete y aprende de los mejores expertos internacionales!